Abcam shares rise after making $340 million acquisition
Shares in life sciences research tools Abcam (ABC:AIM) gained 2% to £13.86 after the company agreed to acquire BioVision for $340 million in cash.The company said that Biovision is a fast-growing distributer of life science tools to...
02 August 2021
